Phytochemical Pharmacology of Ricinus communis Compounds

Ricinus communis, commonly known as the castor plant, is valued for its rich complement of bioactive metabolites, including hydroxy fatty acids (notably ricinoleic acid), alkaloids (such as ricinine), lectins, polyphenols and storage proteins. These phytochemicals exert a broad spectrum of pharmacological actions, ranging from anti-inflammatory and analgesic effects to antimicrobial, anticancer and anti-parasitic activities. Mechanistic studies have revealed modulation of key signalling cascades, enzyme inhibition, regulation of gene expression and induction of programmed cell death as central modes of action. While the seed-derived toxin ricin imposes safety considerations, properly processed extracts and purified constituents have demonstrated low systemic toxicity and promising efficacy.

Global interest in R. communis phytochemistry has driven exploration of castor oil derivatives for topical formulations, antimicrobial agents in veterinary medicine and as potential adjuvants in oncology. Agricultural by-products are increasingly regarded as sustainable sources of high-value compounds. Continued characterisation of molecular targets and standardisation of extraction protocols underpin the translation of traditional uses into modern therapeutic applications.

Research from Nature Portfolio

Recent studies have shown that fruit extracts of R. communis exhibit potent anti-cancer effects in both oestrogen-positive and triple-negative breast cancer models. Treatment of cultured cells resulted in dose-dependent cytotoxicity, marked inhibition of cell migration and invasion through suppression of matrix metalloproteinases 2 and 9, and induction of apoptosis via downregulation of Bcl-2, upregulation of Bax, activation of caspase-7 and PARP cleavage. In an orthotopic mouse model, administration of the active fraction significantly reduced tumour volume. Chemical analysis identified key constituents—ricinine, p-coumaric acid, epigallocatechin and ricinoleic acid—which each displayed individual cytotoxic and anti-migratory activities, establishing a pharmacological basis for further drug development.

Phytochemical Pharmacology of Ricinus communis Compounds publication trend

The graph below shows the total number of articles in phytochemical pharmacology of ricinus communis compounds across all publications each year (not limited to Nature Index journals).

Technical terms

Phytochemical: A bioactive compound produced by plants that contributes to pharmacological effects.

Ricinoleic acid: The principal hydroxy fatty acid in castor oil, responsible for anti-inflammatory and analgesic properties.

Ricinine: An alkaloid isolated from R. communis seeds, notable for antimicrobial and cytotoxic activities.

Matrix metalloproteinases: Enzymes that degrade extracellular matrix proteins, facilitating cell migration and tissue remodelling.

Apoptosis: Programmed cell death involving caspase activation, DNA fragmentation and membrane blebbing.

Minimum inhibitory concentration (MIC): The lowest concentration of an antimicrobial agent that prevents visible growth of a microorganism.

Gene expression profiling: A high-throughput method to measure the activity levels of multiple genes, revealing cellular responses to treatments.

References

1. Ricinus communis L. fruit extract inhibits migration/invasion, induces apoptosis in breast cancer cells and arrests tumor progression in vivo. Scientific Reports (2019).
2. Antibacterial and antifungal activities and phytochemical profile of leaf extract from different extractants of Ricinus communis against selected pathogens. BMC Research Notes (2017).
3. Effect of ricinoleic acid in acute and subchronic experimental models of inflammation. Mediators of Inflammation (2000).
4. Gene expression profiling to elucidate the pharmacological and toxicological effects of Ricinus communis L. leaf extract in mammalian cells. Biotechnology & Biotechnological Equipment (2019).